Literature DB >> 11097444

Spinal deformity in familial dysautonomia. Prevalence, and results of bracing.

S Hayek1, F J Laplaza, F B Axelrod, S W Burke.   

Abstract

BACKGROUND: Familial dysautonomia (Riley-Day syndrome) is an autosomal recessive disorder primarily affecting individuals of Ashkenazi Jewish extraction. It affects the autonomic, central, and peripheral nervous systems. Spinal deformity (mainly scoliosis) is the most common orthopaedic problem in patients with familial dysautonomia. The objectives of our study were to document the prevalence of spinal deformity in a referral center for familial dysautonomia and to determine the effectiveness of bracing.
METHODS: We performed a retrospective radiographic and clinical study of 123 patients with familial dysautonomia who had survived to the age of twenty years or older.
RESULTS: One hundred and two (83 percent) of the 123 patients had spinal deformity: sixty-nine (56 percent) had scoliosis only, thirty-one (25 percent) had scoliosis as well as kyphosis, and two (2 percent) had kyphosis only. Scoliosis was diagnosed by the age of ten years in sixty-four (52 percent) of the patients. Of the sixty-five patients who were treated with bracing, fifty-eight (89 percent) had progression and twenty-four (37 percent) underwent spinal arthrodesis. No risk factors for the presence or progression of the curves could be found.
CONCLUSIONS: The prevalence of spinal deformity in patients with familial dysautonomia who had lived for at least twenty years was found to be 83 percent. By the age of ten years, 52 percent of the patients had scoliosis and 21 percent had kyphosis with or without scoliosis. Bracing was found to be of limited effectiveness as a definitive treatment for spinal deformity. The curve progressed despite bracing in fifty-eight (89 percent) of sixty-five patients.

Entities:  

Mesh:

Year:  2000        PMID: 11097444

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  8 in total

Review 1.  Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations.

Authors:  Mikhail Kazachkov; Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Bat-El Bar-Aluma; Christy L Spalink; Erin P Barnes; Nancy E Amoroso; Stamatela M Balou; Shay Bess; Arun Chopra; Rany Condos; Ori Efrati; Kathryn Fitzgerald; David Fridman; Ronald M Goldenberg; Ayelet Goldhaber; David A Kaufman; Sanjeev V Kothare; Jeremiah Levine; Joseph Levy; Anthony S Lubinsky; Channa Maayan; Libia C Moy; Pedro J Rivera; Alcibiades J Rodriguez; Gil Sokol; Mark F Sloane; Tina Tan; Horacio Kaufmann
Journal:  Respir Med       Date:  2018-06-21       Impact factor: 3.415

Review 2.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

3.  ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia.

Authors:  Elisabetta Morini; Dadi Gao; Connor M Montgomery; Monica Salani; Chiara Mazzasette; Tobias A Krussig; Brooke Swain; Paula Dietrich; Jana Narasimhan; Vijayalakshmi Gabbeta; Amal Dakka; Jean Hedrick; Xin Zhao; Marla Weetall; Nikolai A Naryshkin; Gregory G Wojtkiewicz; Chien-Ping Ko; Michael E Talkowski; Ioannis Dragatsis; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2019-03-21       Impact factor: 11.025

Review 4.  Current treatments in familial dysautonomia.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Cristina Fuente-Mora; Leila Percival; Carlos Mendoza-Santiesteban; Horacio Kaufmann
Journal:  Expert Opin Pharmacother       Date:  2014-10-17       Impact factor: 3.889

5.  Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression.

Authors:  Felicia B Axelrod; Judith D Goldberg; Linda Rolnitzky; James Mull; Sandra P Mann; Gabrielle Gold von Simson; Dena Berlin; Susan A Slaugenhaupt
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

Review 6.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

7.  The familial dysautonomia disease gene IKBKAP is required in the developing and adult mouse central nervous system.

Authors:  Marta Chaverra; Lynn George; Marc Mergy; Hannah Waller; Katharine Kujawa; Connor Murnion; Ezekiel Sharples; Julian Thorne; Nathaniel Podgajny; Andrea Grindeland; Yumi Ueki; Steven Eiger; Cassie Cusick; A Michael Babcock; George A Carlson; Frances Lefcort
Journal:  Dis Model Mech       Date:  2017-02-06       Impact factor: 5.758

Review 8.  Hereditary sensory and autonomic neuropathies: types II, III, and IV.

Authors:  Felicia B Axelrod; Gabrielle Gold-von Simson
Journal:  Orphanet J Rare Dis       Date:  2007-10-03       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.